Nothing Special   »   [go: up one dir, main page]

Hill et al., 1969 - Google Patents

C3 leukotactic factors produced by a tissue protease

Hill et al., 1969

View PDF
Document ID
1925122163322780678
Author
Hill J
Ward P
Publication year
Publication venue
The Journal of Experimental Medicine

External Links

Snippet

When various rat tissues are incubated in homologous serum, a factor chemotactic in vitro for neutrophils is generated. The amount of chemotactic activity is a function of duration of incubation and the quantity of heart tissue or serum employed. Addition of trypsin inhibitor or …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates

Similar Documents

Publication Publication Date Title
Hill et al. C3 leukotactic factors produced by a tissue protease
Vischer et al. In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules.
Taubman et al. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation.
Chensue et al. Modulation of granulomatous hypersensitivity. II. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice.
Ratnoff et al. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor
Cochrane et al. Polymorphonuclear leukocytes in immunologic reactions: the destruction of vascular basement membrane in vivo and in vitro
Cunha et al. The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids
Hausman et al. Humoral mediators of chemotaxis of mononuclear leukocytes
Hoagland et al. Aspects of control of protein synthesis in normal and regenerating rat liver, II. A microsomal inhibitor of amino acid incorporation whose action is antagonized by guanosine triphosphate
Nemerson et al. Purification and characterization of the protein component of tissue factor
Ferreira et al. Toxic activities of venoms from nine Bothrops species and their correlation with lethality and necrosis
Nawroth et al. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture
Kozma et al. A stimulated S6 kinase from rat liver: identity with the mitogen activated S6 kinase of 3T3 cells.
Gromkowski et al. Lack of DNA degradation in target cells lysed by granules derived from cytolytic T lymphocytes.
Borel Studies on chemotaxis
Rafter et al. STUDIES ON THE PATHOGENESIS OF FEVER: XIV. Further Observations on the Chemistry of Leukocytic Pyrogen
Wilkinson Surface and cell membrane activities of leukocyte chemotactic factors
Strunk et al. Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro.
Howes Jr et al. Complement and polymorphonuclear leukocytes do not determine the vascular permeability induced by intraocular LPS.
Ohyabu et al. Studies on phosphatidylinositol phosphodiesterase (phospholipase C type) of Bacillus cereus: II. In vivo and immunochemical studies of phosphatase-releasing activity
Baltz et al. Isolation and characterization of amyloid enhancing factor (AEF)
Higashino et al. Further investigation of a variant of the placental alkaline phosphatase in human hepatic carcinoma
Plow et al. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
Ouyang et al. Purification and properties of the anticoagulant principle of Trimeresurus gramineus venom
Solomkin et al. Cellular and subcellular mediators of acute inflammation